Carla Verri

2.3k total citations · 1 hit paper
29 papers, 1.7k citations indexed

About

Carla Verri is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Carla Verri has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Carla Verri's work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (12 papers) and Extracellular vesicles in disease (5 papers). Carla Verri is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (12 papers) and Extracellular vesicles in disease (5 papers). Carla Verri collaborates with scholars based in Italy, Malaysia and United States. Carla Verri's co-authors include Gabriella Sozzi, Ugo Pastorino, Mattia Boeri, Davide Conte, Luca Roz, Federica Facchinetti, Elisa Calabrò, Paola Suatoni, Piergiorgio Modena and Carlo M. Croce and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Carla Verri

28 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

2011 568 citations Mattia Boeri, Carla Verri et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carla Verri Italy	17	1.1k	1.1k	529	318	152	29	1.7k
Eleonora Rofi Italy	20	621 0.6×	583 0.5×	631 1.2×	563 1.8×	148 1.0×	39	1.4k
Fan Mo Canada	19	667 0.6×	521 0.5×	598 1.1×	320 1.0×	136 0.9×	29	1.3k
Yi‐Rong Liu China	22	865 0.8×	862 0.8×	343 0.6×	523 1.6×	76 0.5×	44	1.6k
Wasim H. Chowdhury United States	19	931 0.8×	445 0.4×	269 0.5×	239 0.8×	71 0.5×	40	1.3k
Yang Xia China	28	1.3k 1.2×	1.1k 1.0×	220 0.4×	175 0.6×	44 0.3×	58	1.7k
Ulrich Andergassen Germany	21	548 0.5×	894 0.8×	434 0.8×	1.3k 3.9×	110 0.7×	73	1.8k
Youtao Xu China	21	1.6k 1.4×	1.4k 1.3×	294 0.6×	249 0.8×	47 0.3×	43	2.0k
Zhaomei Mu United States	22	577 0.5×	605 0.6×	304 0.6×	752 2.4×	57 0.4×	43	1.3k
Kang Shao China	21	841 0.8×	660 0.6×	277 0.5×	302 0.9×	43 0.3×	57	1.3k
Αreti Strati Greece	24	865 0.8×	1.1k 1.1×	426 0.8×	1.0k 3.3×	50 0.3×	48	1.9k

Countries citing papers authored by Carla Verri

Since Specialization

Citations

This map shows the geographic impact of Carla Verri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Verri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Verri more than expected).

Fields of papers citing papers by Carla Verri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Verri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Verri. The network helps show where Carla Verri may publish in the future.

Co-authorship network of co-authors of Carla Verri

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Verri. A scholar is included among the top collaborators of Carla Verri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Verri. Carla Verri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Pastorino, Ugo, Mattia Boeri, Stefano Sestini, et al.. (2022). Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial. Annals of Oncology. 33(4). 395–405. 60 indexed citations

2.

Boeri, Mattia, Massimo Milione, Claudia Proto, et al.. (2019). Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study. Clinical Cancer Research. 25(7). 2166–2173. 64 indexed citations

3.

Pastorino, Ugo, Mattia Boeri, Stefano Sestini, et al.. (2019). PL02.04 Blood MicroRNA and LDCT Reduce Unnecessary LDCT Repeats in Lung Cancer Screening: Results of Prospective BioMILD Trial. Journal of Thoracic Oncology. 14(10). S5–S6. 11 indexed citations

4.

Mensah, Mavis, Cristina Borzi, Carla Verri, et al.. (2017). MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening. Journal of Visualized Experiments. 29 indexed citations

5.

Verri, Carla, Cristina Borzi, Todd Holscher, et al.. (2017). Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening–Detected Lung Cancers. Journal of Thoracic Oncology. 12(6). 922–931. 15 indexed citations

6.

Mensah, Mavis, Cristina Borzi, Carla Verri, et al.. (2017). MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening. Journal of Visualized Experiments. 9 indexed citations

7.

Fortunato, Orazio, Carla Verri, Ugo Pastorino, Gabriella Sozzi, & Mattia Boeri. (2016). MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature. SHILAP Revista de lepidopterología. 5(3). 18–18. 8 indexed citations

8.

Conte, Davide, Carla Verri, Cristina Borzi, et al.. (2015). Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR. BMC Genomics. 16(1). 849–849. 65 indexed citations

9.

Sestini, Stefano, Mattia Boeri, Alfonso Marchianò, et al.. (2015). Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening. Oncotarget. 6(32). 32868–32877. 60 indexed citations

10.

Sozzi, Gabriella, Mattia Boeri, Marta Rossi, et al.. (2014). Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study. Journal of Clinical Oncology. 32(8). 768–773. 318 indexed citations

11.

Fortunato, Orazio, Mattia Boeri, Carla Verri, et al.. (2014). Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients. Molecules. 19(3). 3038–3054. 66 indexed citations

12.

Fortunato, Orazio, Mattia Boeri, Massimo Moro, et al.. (2014). Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction. Cell Death and Disease. 5(12). e1564–e1564. 68 indexed citations

13.

Fortunato, Orazio, Mattia Boeri, Carla Verri, Massimo Moro, & Gabriella Sozzi. (2014). Therapeutic Use of MicroRNAs in Lung Cancer. BioMed Research International. 2014. 1–8. 45 indexed citations

14.

Fortunato, Orazio, Mattia Boeri, Carla Verri, et al.. (2014). Abstract A19: Origin and functional role of plasma circulating miRNAs.. Clinical Cancer Research. 20(2_Supplement). A19–A19. 1 indexed citations

15.

Levenson, Victor, Anatoliy A. Melnikov, Qilong Yi, et al.. (2014). Non-Small Cell Lung Cancer can be Detected and its Subtypes Differentiated by a Blood Test of Methylation in Cell-Free DNA from Plasma. 2 indexed citations

16.

Brenca, Monica, Mattia Boeri, Carla Verri, et al.. (2014). YAP1acts as oncogenic target of 11q22 amplification in multiple cancer subtypes. Oncotarget. 5(9). 2608–2621. 56 indexed citations

17.

Cremona, Mattia, Elisa Calabrò, G. Randi, et al.. (2010). Elevated levels of the acute‐phase serum amyloid are associated with heightened lung cancer risk. Cancer. 116(5). 1326–1335. 20 indexed citations

18.

Verri, Carla, Luca Roz, Davide Conte, et al.. (2008). Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project. American Journal of Respiratory and Critical Care Medicine. 179(5). 396–401. 52 indexed citations

19.

Sozzi, Gabriella, Luca Roz, Davide Conte, et al.. (2008). Plasma DNA Quantification in Lung Cancer Computed Tomography Screening. American Journal of Respiratory and Critical Care Medicine. 179(1). 69–74. 83 indexed citations

20.

Verri, Carla, et al.. (1989). Treatment of advanced colorectal and gastric cancer with 5-fluorouracil and calcium n-methyltetrahydrofolate.. PubMed. 1(4 Suppl). 1212–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact